Ponazuril Oral Suspension (Anhydrous)

How to Give Anhydrous Oral Suspension

Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:

1. Shake well each time to mix the medication (5-10 seconds).
2. Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
3. Hold your pet steady: a towel or helper can assist with squirmy pets.
4. Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
5. Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
6. Praise your pet and offer a treat or water (unless advised against feeding right after).
7. Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
8. Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.

Veterinarians most commonly consider ponazuril when a horse is presented with clinical signs associated with Equine Protozoal Myeloencephalitis (EPM). It is also frequently discussed in small animal practice for the management of coccidiosis or other protozoal challenges where targeted intervention is a clinical objective. By addressing the replication of specific protozoal organisms, your veterinarian can manage the parasitic landscape within the patient’s central nervous system or gastrointestinal tract.

At a pharmacological level, ponazuril acts by targeting the apicoplast—a specialized organelle found in certain protozoa, such as Sarcocystis neurona. It interferes with the parasite's ability to maintain essential metabolic functions, inhibiting its replication and survival within the host. Because ponazuril is characterized by its ability to cross the blood-brain barrier, it is a frequent point of clinical focus for neurological conditions triggered by protozoal organisms. Your veterinarian will determine whether ponazuril is appropriate for your pet based on weight, species and specific diagnostic findings.

The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.

Commonly observed effects of ponazuril administration include mild gastrointestinal changes, such as loose stools or a temporary decrease in appetite. In horses, some owners have observed localized skin irritation, hives or a slight change in coordination shortly after administration. In small animals, transient lethargy or vomiting may occur. Your veterinarian will monitor for these responses and may recommend regular clinical assessments during the course of the prescription.This medication is typically used with caution in patients with known liver or kidney impairment, as these organs are involved in the metabolic processing and elimination of the medication. It is also carefully evaluated in pregnant or lactating animals, as the safety profile for developing offspring has not been fully characterized in every species. Before starting a protocol involving ponazuril, ensure your veterinarian has a complete history of all other supplements and medications your pet is receiving. Contact your veterinarian promptly if you observe significant behavioral shifts, persistent diarrhea or signs of an allergic reaction during the administration period.